newsfilter
← Latest News
GlobeNewswire·

Sema4 Announces Preliminary Revenue for the Fourth Quarter and Fiscal Year 2021

STAMFORD, Conn., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Sema4 (NASDAQ:SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced preliminary revenue (unaudited) for the fourth quarter and fiscal year ended December 31, 2021